2013
Differential long‐term outcomes of zotarolimus‐eluting stents compared with sirolimus‐eluting and paclitaxel‐eluting stents in diabetic and nondiabetic patients: Two‐year subgroup analysis of the ZEST randomized trial
Jang S, Park D, Kim W, Kim Y, Yun S, Kang S, Lee S, Lee C, Park S, Park S. Differential long‐term outcomes of zotarolimus‐eluting stents compared with sirolimus‐eluting and paclitaxel‐eluting stents in diabetic and nondiabetic patients: Two‐year subgroup analysis of the ZEST randomized trial. Catheterization And Cardiovascular Interventions 2013, 81: 1106-1114. PMID: 22899589, DOI: 10.1002/ccd.24603.Peer-Reviewed Original ResearchMeSH KeywordsAgedCardiovascular AgentsChi-Square DistributionCoronary AngiographyCoronary Artery DiseaseCoronary ThrombosisDiabetes MellitusDrug-Eluting StentsFemaleHumansKaplan-Meier EstimateMaleMiddle AgedMyocardial InfarctionPaclitaxelPercutaneous Coronary InterventionProportional Hazards ModelsProspective StudiesProsthesis DesignRepublic of KoreaRisk AssessmentRisk FactorsSirolimusTime FactorsTreatment OutcomeConceptsMajor adverse cardiac eventsPaclitaxel-eluting stentsZotarolimus-eluting stentsSirolimus-eluting stentsNondiabetic patientsDiabetic statusDiabetic patientsStent typeIschemia-driven target vessel revascularizationDifferential long-term outcomesLower ratesAdverse cardiac eventsComposite of deathTarget vessel revascularizationLong-term outcomesDifferential treatment effectsSimilar ratesAngiographic characteristicsIschemic complicationsCardiac eventsDiabetes mellitusPrimary outcomeMACE occurrenceStent groupMyocardial infarction
2012
Association of early systolic blood pressure response to exercise with future cardiovascular events in patients with uncomplicated mild-to-moderate hypertension
Cho M, Jang S, Lee C, Park C. Association of early systolic blood pressure response to exercise with future cardiovascular events in patients with uncomplicated mild-to-moderate hypertension. Hypertension Research 2012, 35: 922-927. PMID: 22534519, PMCID: PMC3434366, DOI: 10.1038/hr.2012.52.Peer-Reviewed Original ResearchConceptsFuture cardiovascular eventsBlood pressure responseCardiovascular eventsSustained hypertensionSystolic BPQuartiles 3New onset ischemic heart diseaseSurvival rateEvent-free survival rateSystolic blood pressure responseComposite end pointIschemic heart diseaseTarget heart ratePressure responseCause deathModerate hypertensionMultivariable adjustmentCardiovascular riskSBP responseUncomplicated mildPrimary outcomeQuartiles 1Heart diseaseMonitoring registryExercise test